دورية أكاديمية

Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.

التفاصيل البيبلوغرافية
العنوان: Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.
المؤلفون: Okar SV; From the Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, USA (S.V.O., E.S.B., M.I.G., M.A., D.S.R.); qMRI Core facility, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, USA (H.D., G.N.); Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA (E.S.B.); Office of Biostatistics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA (G.N.); Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, Bethesda, MD, USA (D.L.P.); Division of Neuroscience, Vita-Salute San Raffaele University and Hospital, Milan, Italy (M.A.); Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA (M.A.); Experimental Immunotherapeutics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA (I.C.M.C.); Neuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA (A.F.); and Viral Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD20814, USA (S.J.)., Dieckhaus H, Beck ES, Gaitán MI, Norato G, Pham DL, Absinta M, Cortese IC, Fletcher A, Jacobson S, Nair G, Reich DS
المصدر: Investigative radiology [Invest Radiol] 2024 Mar 01; Vol. 59 (3), pp. 243-251.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0045377 Publication Model: Print Cited Medium: Internet ISSN: 1536-0210 (Electronic) Linking ISSN: 00209996 NLM ISO Abbreviation: Invest Radiol Subsets: MEDLINE
أسماء مطبوعة: Publication: 1998- : Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Philadelphia.
مواضيع طبية MeSH: Multiple Sclerosis*/pathology, Humans ; Female ; Adult ; Middle Aged ; Magnetic Resonance Imaging ; Meninges/diagnostic imaging ; Meninges/pathology ; Inflammation/pathology
مستخلص: Background: Leptomeningeal contrast enhancement (LME) on T2-weighted Fluid-Attenuated Inversion Recovery (T2-FLAIR) MRI is a reported marker of leptomeningeal inflammation, which is known to be associated with progression of multiple sclerosis (MS). However, this MRI approach, as typically implemented on clinical 3-tesla (T) systems, detects only a few enhancing foci in ~25% of patients and has thus been criticized as poorly sensitive.
Purpose: To compare an optimized 3D real-reconstruction inversion recovery (Real-IR) MRI sequence on a clinical 3 T scanner to T2-FLAIR for prevalence, characteristics, and clinical/radiological correlations of LME.
Materials and Methods: We obtained 3D T2-FLAIR and Real-IR scans before and after administration of standard-dose gadobutrol in 177 scans of 154 participants (98 women, 64%; mean ± SD age: 49 ± 12 years), including 124 with an MS-spectrum diagnosis, 21 with other neurological and/or inflammatory disorders, and 9 without neurological history. We calculated contrast-to-noise ratios (CNR) in 20 representative LME foci and determined association of LME with cortical lesions identified at 7 T (n = 19), paramagnetic rim lesions (PRL) at 3 T (n = 105), and clinical/demographic data.
Results: We observed focal LME in 73% of participants on Real-IR (70% in established MS, 33% in healthy volunteers, P < 0.0001), compared to 33% on T2-FLAIR (34% vs. 11%, P = 0.0002). Real-IR showed 3.7-fold more LME foci than T2-FLAIR ( P = 0.001), including all T2-FLAIR foci. LME CNR was 2.5-fold higher by Real-IR ( P < 0.0001). The major determinant of LME status was age. Although LME was not associated with cortical lesions, the number of PRL was associated with the number of LME foci on both T2-FLAIR ( P = 0.003) and Real-IR ( P = 0.0003) after adjusting for age, sex, and white matter lesion volume.
Conclusions: Real-IR a promising tool to detect, characterize, and understand the significance of LME in MS. The association between PRL and LME highlights a possible role of the leptomeninges in sustaining chronic inflammation.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
References: Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain . 2011;134(Pt 9):2755–2771.
Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain . 2007;130(Pt 4):1089–1104.
Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med . 2011;365:2188–2197.
Ahmed SM, Fransen NL, Touil H, et al. Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis. JCI Insight . 2022;7:e151683.
Zurawski J, Lassmann H, Bakshi R. Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review. JAMA Neurol . 2017;74:100–109.
Absinta M, Cortese IC, Vuolo L, et al. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology . 2017;88:1439–1444.
Ineichen BV, Tsagkas C, Absinta M, et al. Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: a systematic review and Meta-analysis. Neuroimage Clin . 2022;33:102939.
Zivadinov R, Ramasamy DP, Vaneckova M, et al. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: a retrospective, pilot, observational longitudinal study. Mult Scler . 2017;23:1336–1345.
Ighani M, Jonas S, Izbudak I, et al. No association between cortical lesions and leptomeningeal enhancement on 7-tesla MRI in multiple sclerosis. Mult Scler . 2020;26:165–176.
Harrison DM, Wang KY, Fiol J, et al. Leptomeningeal enhancement at 7 T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J Neuroimaging . 2017;27:461–468.
Makshakov G, Magonov E, Totolyan N, et al. Leptomeningeal contrast enhancement is associated with disability progression and Grey matter atrophy in multiple sclerosis. Neurol Res Int . 2017;2017:8652463.
Absinta M, Vuolo L, Rao A, et al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology . 2015;85:18–28.
Wattjes MP, Killestein J. Imaging of meningeal inflammation should become part of the routine MRI protocol – no. Mult Scler J . 2019;25:331–333.
Naganawa S, Kawai H, Taoka T, et al. Improved 3D-real inversion recovery: a robust imaging technique for endolymphatic Hydrops after intravenous Administration of Gadolinium. Magn Reson Med Sci . 2019;18:105–108.
Busse RF, Brau AC, Vu A, et al. Effects of refocusing flip angle modulation and view ordering in 3D fast spin echo. Magn Reson Med . 2008;60:640–649.
Park HW, Cho MH, Cho ZH. Real-value representation in inversion-recovery NMR imaging by use of a phase-correction method. Magn Reson Med . 1986;3:15–23.
Absinta M, Sati P, Masuzzo F, et al. Association of Chronic Active Multiple Sclerosis Lesions with Disability in Vivo. JAMA Neurol . 2019;76:1474–1483.
Beck ES, Sati P, Sethi V, et al. Improved visualization of cortical lesions in multiple sclerosis using 7 T MP2RAGE. AJNR Am J Neuroradiol . 2018;39:459–466.
Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol . 2018;17:162–173.
Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology . 2009;72:800–805.
WHO. Human T lymphotropic virus type 1, HTLV-1. Wkly Epidemiol Rec . 1989;64:382–383.
Zivadinov R, Ramasamy DP, Hagemeier J, et al. Evaluation of leptomeningeal contrast enhancement using pre-and Postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis. AJNR Am J Neuroradiol . 2018;39:642–647.
Liu J, Beck ES, Filippini S, et al. Navigator-guided motion and B0 correction of T2*-weighted magnetic resonance imaging improves multiple sclerosis cortical lesion detection. Invest Radiol . 2021;56:409–416.
Beck ES, Maranzano J, Luciano NJ, et al. Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis. Mult Scler . 2022;28:1351–1363.
Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage . 2006;31:1116–1128.
Dieckhaus H, Meijboom R, Okar S, et al. Logistic regression-based model is more efficient than U-net model for reliable whole brain magnetic resonance imaging segmentation. Top Magn Reson Imaging . 2022;31:31–39.
Freeze WM, Schnerr RS, Palm WM, et al. Pericortical enhancement on delayed Postgadolinium fluid-attenuated inversion recovery images in Normal aging, mild cognitive impairment, and Alzheimer disease. AJNR Am J Neuroradiol . 2017;38:1742–1747.
Naganawa S, Nakane T, Kawai H, et al. Age dependence of gadolinium leakage from the cortical veins into the cerebrospinal fluid assessed with whole brain 3D-real inversion recovery MR imaging. Magn Reson Med Sci . 2019;18:163–169.
Dema M, Eixarch H, Villar LM, et al. Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. Autoimmun Rev . 2021;20:102893.
Picon C, Tejeda-Velarde A, Fernandez-Velasco JI, et al. Identification of the immunological changes appearing in the CSF during the early Immunosenescence process occurring in multiple sclerosis. Front Immunol . 2021;12:685139.
Cai W, Zhang K, Li P, et al. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect. Ageing Res Rev . 2017;34:77–87.
Zurawski J, Tauhid S, Chu R, et al. 7 T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler . 2020;26:177–187.
Bergsland N, Ramasamy D, Tavazzi E, et al. Leptomeningeal contrast enhancement is related to focal cortical thinning in relapsing-remitting multiple sclerosis: a cross-sectional MRI study. AJNR Am J Neuroradiol . 2019;40:620–625.
Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol . 2010;68:477–493.
Bhargava P, Kim S, Reyes AA, et al. Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition. Brain . 2021;144:1396–1408.
Jonas SN, Izbudak I, Frazier AA, et al. Longitudinal persistence of meningeal enhancement on Postcontrast 7 T 3D-FLAIR MRI in multiple sclerosis. AJNR Am J Neuroradiol . 2018;39:1799–1805.
معلومات مُعتمدة: Z99 NS999999 United States ImNIH Intramural NIH HHS
تواريخ الأحداث: Date Created: 20230726 Date Completed: 20240214 Latest Revision: 20240621
رمز التحديث: 20240622
مُعرف محوري في PubMed: PMC10818009
DOI: 10.1097/RLI.0000000000001011
PMID: 37493285
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-0210
DOI:10.1097/RLI.0000000000001011